DURECT CORP (DRRX)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch DRRX
See up to 3 months of DRRX. The 7-day demo opens the 1M and 3M ranges and puts DRRX on your watchlist.
Start 7-day demoLatest DRRX insider trades
About DURECT CORP (DRRX)
DURECT CORP files with the SEC under CIK 0001082038 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
DRRX Form 4 activity by transaction type, last 90 days
No Form 4 activity for DRRX in the last 90 days.
DRRX insider transactions (Form 4)
6523 Form 4 filings on record, the earliest from Oct 16, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Judith J. Robertson | Other | Common Stock | 41,113 | - | - | |
| Judith J. Robertson | Derivative | Stock Option (right to buy) | 7,000 | - | - | |
| Judith J. Robertson | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Judith J. Robertson | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Judith J. Robertson | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Judith J. Robertson | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
 Gail J. Maderis | Other | Common Stock | 5,500 | - | - | |
| Gail J. Maderis | Other | Common Stock | 20,000 | - | - | |
| Gail J. Maderis | Derivative | Stock Option (right to buy) | 7,000 | - | - | |
| Gail J. Maderis | Derivative | Stock Option (right to buy) | 2,750 | - | - | |
| Gail J. Maderis | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Gail J. Maderis | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Norman Sussman - Officer | Derivative | Common Stock | 46,425 | - | - | |
| Norman Sussman - Officer | Derivative | Stock Option (right to buy) | 20,000 | - | - | |
| Norman Sussman - Officer | Derivative | Stock Option (right to buy) | 10,000 | - | - | |
| Norman Sussman - Officer | Derivative | Stock Option (right to buy) | 39,837 | - | - | |
| Norman Sussman - Officer | Derivative | Stock Option (right to buy) | 69,557 | - | - | |
| Norman Sussman - Officer | Derivative | Stock Option (right to buy) | 104,000 | - | - | |
 Gail M. Farfel | Other | Common Stock | 15,500 | - | - | |
| Gail M. Farfel | Derivative | Stock Option (right to buy) | 7,000 | - | - | |
| Gail M. Farfel | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Gail M. Farfel | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Gail M. Farfel | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Gail M. Farfel | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Peter S. Garcia | Other | Common Stock | 12,500 | - | - | |
| Peter S. Garcia | Derivative | Stock Option (right to buy) | 7,000 | - | - | |
| Peter S. Garcia | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Peter S. Garcia | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
 Mohammad Azab | Other | Common Stock | 6,000 | - | - | |
| Mohammad Azab | Derivative | Stock Option (right to buy) | 7,000 | - | - | |
| Mohammad Azab | Derivative | Stock Option (right to buy) | 2,750 | - | - | |
| Mohammad Azab | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Mohammad Azab | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Mohammad Azab | Derivative | Stock Option (right to buy) | 5,500 | - | - | |
| Timothy M. Papp - Officer | Other | Common Stock | 385,000 | - | - | |
| Timothy M. Papp - Officer | Derivative | Common Stock | 46,659 | - | - | |
| Timothy M. Papp - Officer | Derivative | Stock Option (right to buy) | 60,000 | - | - | |
| Timothy M. Papp - Officer | Derivative | Stock Option (right to buy) | 12,377 | - | - | |
| Timothy M. Papp - Officer | Derivative | Stock Option (right to buy) | 60,000 | - | - | |
 James E. Brown - Officer | Derivative | Stock Option (right to buy) | 103,077 | - | - | |
| Gail M. Farfel | Option exercise | Common Stock | 5,500 | $1.22 | $7K | |
| Gail M. Farfel | Option exercise | Stock Option (right to buy) | 5,500 | $0.00 | - | |
| Judith J. Robertson | Option exercise | Common Stock | 5,500 | $1.22 | $7K | |
| Judith J. Robertson | Option exercise | Stock Option (right to buy) | 5,500 | $0.00 | - | |
| James E. Brown - Officer | Option exercise | Common Stock | 131,923 | $1.30 | $171K | |
| James E. Brown - Officer | Option exercise | Common Stock | 130,000 | $1.30 | $169K | |
| James E. Brown - Officer | Option exercise | Stock Option (right to buy) | 131,923 | $0.00 | - | |
| James E. Brown - Officer | Option exercise | Stock Option (right to buy) | 130,000 | $0.00 | - | |
| Peter S. Garcia | Option exercise | Common Stock | 5,500 | $1.22 | $7K | |
| Peter S. Garcia | Option exercise | Stock Option (right to buy) | 5,500 | $0.00 | - | |
| Gail J. Maderis | Option exercise | Common Stock | 5,500 | $1.22 | $7K | |
| Gail J. Maderis | Option exercise | Stock Option (right to buy) | 5,500 | $0.00 | - | |
| James E. Brown - Officer | Option exercise | Common Stock | 10,000 | $1.30 | $13K | |
| James E. Brown - Officer | Option exercise | Stock Option (right to buy) | 10,000 | $0.00 | - | |
| Timothy M. Papp - Officer | Option exercise | Common Stock | 110,000 | $1.30 | $143K | |
| Timothy M. Papp - Officer | Option exercise | Stock Option (right to buy) | 110,000 | $0.00 | - | |
| R. Scott Asen - 10% Owner | Open-market purchase | Common Stock | 5,917 | $1.92 | $11K | |
| R. Scott Asen - 10% Owner | Open-market purchase | Common Stock | 87,608 | $1.89 | $165K | |
| R. Scott Asen - 10% Owner | Open-market purchase | Common Stock | 116,612 | $1.90 | $221K | |
| Norman Sussman - Officer | Grant or award | Common Stock | 46,425 | $0.00 | - | |
| James E. Brown - Officer | Grant or award | Common Stock | 96,959 | $0.00 | - | |
| Timothy M. Papp - Officer | Grant or award | Common Stock | 46,659 | $0.00 | - | |
| Norman Sussman - Officer | Grant or award | Stock Option (right to buy) | 104,000 | $0.00 | - | |
| Timothy M. Papp - Officer | Grant or award | Stock Option (right to buy) | 110,000 | $0.00 | - | |
| James E. Brown - Officer | Grant or award | Stock Option (right to buy) | 375,000 | $0.00 | - |
DRRX insider trading FAQ
What is the latest insider trade for DRRX?
DURECT CORP (DRRX) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-09-11. The full record for DRRX runs to 23 Form 4 filings, the earliest from 2024-10-16. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying DRRX stock?
No insider purchases of DRRX were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling DRRX stock?
No insider sales of DRRX were filed in the last 90 days.
Where can I see DRRX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects DRRX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Judith J. Robertson view on EDGAR
- - Gail J. Maderis view on EDGAR
- - Norman Sussman view on EDGAR
- - Gail M. Farfel view on EDGAR
- - Peter S. Garcia view on EDGAR
- - Mohammad Azab view on EDGAR
- - Timothy M. Papp view on EDGAR
- - James E. Brown view on EDGAR
- - Gail M. Farfel view on EDGAR
- - Judith J. Robertson view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where DRRX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow DRRX with a 7-day demo
- DRRX on your watchlist
- Every DRRX Form 4 filing on record
- Up to 3 months of DRRX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
